|
|
Xiaojie Xian, Joakim Håkansson, Anders Ståhlberg, Per Lindblom, Christer Betsholtz, Holger Gerhardt, Henrik Semb
J Clin Invest. 2006;
116(3):642
doi:10.1172/JCI25705
Abstract |
Full text
| PDF

P
reviously we observed that neural cell adhesion molecule (NCAM) deficiency in β tumor cells facilitates metastasis into distant organs and local lymph nodes. Here, we show that NCAM-deficient β cell tumors grew leaky blood vessels with perturbed pericyte-endothelial cell-cell interactions and deficient perivascular deposition of ECM components. Conversely, tumor cell expression of NCAM in a fibrosarcoma model (T241) improved pericyte recruitment and increased perivascular deposition of ECM molecules. Together, these findings suggest that NCAM may limit tumor cell metastasis by stabilizing the microvessel wall. To directly address whether pericyte dysfunction increases the metastatic potential of solid tumors, we studied β cell tumorigenesis in primary pericyte-deficient Pdgfbret/ret mice. This resulted in β tumor cell metastases in distant organs and local lymph nodes, demonstrating a role for pericytes in limiting tumor cell metastasis. These data support a new model for how tumor cells trigger metastasis by perturbing pericyte-endothelial cell-cell interactions.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(40)
| Title and authors |
Publication |
Year |
Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
Vesselina G. Cooke, Valerie S. LeBleu, Doruk Keskin, Zainab Khan, Joyce T. O'Connell, Yingqi Teng, Michael B. Duncan, Liang Xie, Genta Maeda, Sylvia Vong
|
Cancer Cell
|
2012 |
Pericytes on the Tumor Vasculature: Jekyll or Hyde?
Keith D. Barlow, Anne M. Sanders, Shay Soker, Suleyman Ergun, Linda J. Metheny-Barlow
|
Cancer Microenvironment
|
2012 |
Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
Roberta Mazzieri, Ferdinando Pucci, Davide Moi, Erika Zonari, Anna Ranghetti, Alvise Berti, Letterio S. Politi, Bernhard Gentner, Jeffrey L. Brown, Luigi Naldini, Michele De Palma
|
Cancer Cell
|
2011 |
Endometrial bleeding in postmenopausal women
David F. Archer
|
Menopause
|
2011 |
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
John M. L. Ebos, Robert S. Kerbel
|
Nat Rev Clin Oncol
|
2011 |
Antiangiogenic therapy accelerates tumor metastasis
Domenico Ribatti
|
Leukemia Research
|
2011 |
Developmental and Pathological Angiogenesis
Alicia S. Chung, Napoleone Ferrara
|
Annu. Rev. Cell Dev. Biol.
|
2011 |
Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma
Hung Huynh, Pierce Kah Hoe Chow, Wai Ming Tai, Su Pin Choo, Alexander Yaw Fui Chung, Hock Soo Ong, Khee Chee Soo, Richard Ong, Ronald Linnartz, Michael Ming Shi
|
Journal of Hepatology
|
2011 |
Mechanisms of resistance to antiangiogenesis therapy
Faisal Azam, Shaveta Mehta, Adrian L. Harris
|
European Journal of Cancer
|
2010 |
A Digest on the Role of the Tumor Microenvironment in Gastrointestinal Cancers
Martin Augsten, Christina Hägglöf, Cristina Peña, Arne Östman
|
Cancer Microenvironment
|
2010 |
|